discussing the results from the zuma-1 trial for patients with advanced lymphoma
Published 6 years ago • 70 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
1:52
long-term results of zuma-1 trial for patients with nhl
-
2:03
long-term follow-up results from the zuma-1 trial in non-hodgkin lymphoma
-
0:53
design of the zuma-1 trial in non-hodgkin lymphoma
-
0:46
key takeaway from 2-year follow-up data of zuma-1 trial in large b-cell lymphoma
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
1:14
results of the zuma-1 trial exploring kte-c19 in nhl
-
2:02
dr. neelapu on updated zuma-1 findings in non-hodgkin lymphoma
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
3:31
zuma-1 trial observations
-
4:52
long term follow up on the zuma-1 trial for nhl
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
2:13
car-t in dlbcl: 4-year follow-up data from zuma-1
-
1:43
sattva neelapu, md, elaborates on long-term results from the zuma-1 trial
-
4:19
the pivotal zuma-1 trial for nhl
-
2:59
axi-cel in older patients: data from zuma-1 and clinical use
-
1:03
sattva neelapu, md, discusses the results of the zuma-1 pivotal phase 2 study with kte-c19
-
6:03
clinical data for axi-cel in lymphoma